Stanford University: Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

The registry lists 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies with Stanford University as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 1 7Phase 2 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCTRecruitingNCT06551584Phase 1
• Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell MalignanciesRecruitingNCT06408194Phase 1
• Ipilimumab and Local Radiation for Selected Solid TumorsTerminatedNCT01769222Phase 1Results posted
• Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT01769209Phase 2Results posted
• Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T CellCompletedNCT01660607Phase 1/2Results posted
• Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaTerminatedNCT01401322Phase 2Results posted
• Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic LeukemiaActive, not recruitingNCT05993949Phase 1
• Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell MalignanciesActive, not recruitingNCT03241940Phase 1
• Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
• Feasibility Neurocognitive Outcome After TransplantCompletedNCT02300961Not applicable
• Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and VomitingWithdrawnNCT01492569Not applicable
• Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic LeukemiaWithdrawnNCT01162031Phase 2
• T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric AnalysisCompletedNCT01078337
• Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)TerminatedNCT00185523